Evermay Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,090
Closed -$307K 170
2019
Q3
$307K Sell
3,090
-565
-15% -$53.7K 0.08% 115
2019
Q2
$338K Sell
3,655
-440
-11% -$41.8K 0.09% 104
2019
Q1
$386K Sell
4,095
-724
-15% -$63.3K 0.11% 91
2018
Q4
$309K Buy
4,819
+556
+13% +$41K 0.1% 95
2018
Q3
$381K Buy
4,263
+60
+1% +$5.3K 0.12% 93
2018
Q2
$334K Sell
4,203
-85
-2% -$7.06K 0.11% 97
2018
Q1
$383K Sell
4,288
-135
-3% -$13K 0.13% 85
2017
Q4
$462K Buy
4,423
+2,535
+134% +$286K 0.17% 67
2017
Q3
$275K Buy
1,888
+95
+5% +$12.9K 0.12% 74
2017
Q2
$233K Hold
1,793
0.1% 85
2017
Q1
$223K Sell
1,793
-500
-22% -$59.8K 0.1% 90
2016
Q4
$265K Hold
2,293
0.13% 60
2016
Q3
$240K Sell
2,293
-100
-4% -$10.8K 0.12% 66
2016
Q2
$236K Buy
2,393
+41
+2% +$4.24K 0.12% 66
2016
Q1
$235K Buy
2,352
+300
+15% +$30.9K 0.13% 66
2015
Q4
$246K Sell
2,052
-479
-19% -$55.4K 0.14% 63
2015
Q3
$274K Buy
2,531
+73
+3% +$9.06K 0.16% 62
2015
Q2
$284K Hold
2,458
0.17% 64
2015
Q1
$283K Hold
2,458
0.17% 67
2014
Q4
$275K Sell
2,458
-100
-4% -$10.5K 0.18% 69
2014
Q3
$242K Hold
2,558
0.21% 68
2014
Q2
$220K Buy
+2,558
New +$195K 0.19% 75

Other funds holding CELG

Evermay Wealth Management's CELG Position: Q4 2019 in Review

Evermay Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,090 shares — an estimated $307K sold.

Evermay Wealth Management first reported a position in CELG in Q2 2014 and held it in 22 quarters. The position peaked at $462K in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Evermay Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Evermay Wealth Management sold 3,090 Celgene Corp shares in Q4 2019, an estimated $307K.
  • Evermay Wealth Management first reported a position in Celgene Corp in Q2 2014 and held it in 22 quarters.
  • Evermay Wealth Management's Celgene Corp position peaked at $462K in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Evermay Wealth Management's 13F filing for Q4 2019, filed 11 Feb 2020.